Cytokine Pathways in Allergic Disease

Toxicologic Pathology

Volumn 40, Issue 2, 2012, Pages 205-215

  Williams, Cara M M ^a   Rahman, Saifur ^a   Hubeau, Cedric ^a   ma, Hak Ling ^a  

^a PFIZER INC   (United States)

Author keywords

allergy; IL 13; IL 25; IL 33; IL 4; IL 9; TSLP

Indexed keywords

EOTAXIN; EOTAXIN 2; I KAPPA B; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 8; INTERLEUKIN 9; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; STAT6 PROTEIN; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; DOWN REGULATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; TH2 CELL; UPREGULATION;

CYTOKINES; HUMANS; HYPERSENSITIVITY; SIGNAL TRANSDUCTION;

ANIMALIA; PYROGLYPHIDAE;

EID: 84858791002     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623311430694     Document Type: Article

References (136)

1. Abdelilah S. G. Latifa K. Esra N. Cameron L. Bouchaib L. Nicolaides N. C. Levitt R. C. Hamid Q. (2001). Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: Role in IL-8 release. J Immunol 166, 2768–74.
2. Akdis M. Burgler S. Crameri R. Eiwegger T. Fujita H. Gomez E. Klunker S. Meyer N. O’Mahony L. Palomares O. Rhyner C. Quaked N. Schaffartzik A. Van De Veen W. Zeller S. Zimmermann M. Akdis C. A. (2011). Interleukins, from 1 to 37, and interferon-[gamma]: Receptors, functions, and roles in diseases. J Allergy Clin Immunol 127, 701–21.e770.
3. Allakhverdi Z. Smith D. E. Comeau M. R. Delespesse G. (2007). Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179, 2051–54.
4. Angkasekwinai P. Chang S. H. Thapa M. Watarai H. Dong C. (2010). Regulation of IL-9 expression by IL-25 signaling. Nat Immunol 11, 250–56.
5. Angkasekwinai P. Park H. Wang Y.-H. Wang Y.-H. Chang S. H. Corry D. B. Liu Y.-J. Zhu Z. Dong C. (2007). Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 204, 1509–17.
6. Ballantyne S. J. Barlow J. L. Jolin H. E. Nath P. Williams A. S. Chung K. F. Sturton G. Wong S. H. McKenzie A. N. J. (2007). Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 120, 1324–31.
7. Barlow J. L. McKenzie A. N. (2011). Nuocytes: Expanding the innate cell repertoire in type-2 immunity. J Leukoc Biol 90, 867–74.
8. Besnard A.-G. Togbe D. Guillou N. Erard F. Quesniaux V. Ryffel B. (2011). IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol 41, 1675–86.
9. P.R., Bhathena, S.S.A., Comhair, K.J., Holroyd, S.C., Erzurum, Interleukin-9 receptor expression in asthmatic airways, Lung, (2000), 178, 149-160
10. Blázquez A. B. Mayer L. Berin M. C. (2010). Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. Gastroenterology 139, 1301–9.e1304.
11. Bourgeois E. Van L. P. Samson M. Diem S. Barra A. Roga S. Gombert J.-M. Schneider E. Dy M. Gourdy P. Girard J.-P. Herbelin A. (2009). The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur J Immunol 39, 1046–55.
12. Bradding P. Feather I. H. Howarth P. H. Mueller R. Roberts J. A. Britten K. Bews J. P. Hunt T. C. Okayama Y. Heusser C. H. (1992). Interleukin 4 is localized to and released by human mast cells. J Exp Med 176, 1381–86.
13. Brightling C. E. Symon F. A. Holgate S. T. Wardlaw A. J. Pavord I. D. Bradding P. (2003). Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma. Clin Exp Allergy 33, 1711–16.
14. Chackerian A. A. Oldham E. R. Murphy E. E. Schmitz J. Pflanz S. Kastelein R. A. (2007). IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179, 2551–55.
15. Chang H.-C. Han L. Jabeen R. Carotta S. Nutt S. L. Kaplan M. H. (2009). PU.1 regulates TCR expression by modulating GATA-3 activity. J Immunol 183, 4887–94.
16. Chang H.-C. Zhang S. Thieu V. T. Slee R. B. Bruns H. A. Laribee R. N. Klemsz M. J. Kaplan M. H. (2005). PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22, 693–703.
17. Chatila T. A. (2004). Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med 10, 493–99.
18. Cherry W. B. Yoon J. Bartemes K. R. Iijima K. Kita H. (2008). A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 121, 1484–90.
19. Chiba Y. Todoroki M. Misawa M. (2009). Activation of signal transducer and activator of transcription factor 1 by interleukins-13 and -4 in cultured human bronchial smooth muscle cells. J Smooth Muscle Res 45, 279–88.
20. Chow J. Y. Wong C. K. Cheung P. F. Lam C. W. (2010). Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: Implications for allergic inflammation. Cell Mol Immunol 7, 26–34.
21. Corrigan C. J. Wang W. Meng Q. Fang C. Eid G. Caballero M. R. Lv Z. An Y. Wang Y.-H. Liu Y.-J. Kay A. B. Lee T. H. Ying S. (2011). Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 128, 116–24.
22. Cosmi L. Liotta F. Angeli R. Mazzinghi B. Santarlasci V. Manetti R. Lasagni L. Vanini V. Romagnani P. Maggi E. Annunziato F. Romagnani S. (2004). Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103, 3117–21.
23. Dardalhon V. Awasthi A. Kwon H. Galileos G. Gao W. Sobel R. A. Mitsdoerffer M. Strom T. B. Elyaman W. Ho I. C. Khoury S. Oukka M. Kuchroo V. K. (2008). IL-4 inhibits TGF-[beta]-induced Foxp3+ T cells and, together with TGF-[beta], generates IL-9+ IL-10+ Foxp3- effector T cells. Nat Immunol 9, 1347–55.
24. de Waal Malefyt R. Abrams J. S. Zurawski S. M. Lecron J. C. Mohan-Peterson S. Sanjanwala B. Bennett B. Silver J. de Vries J. E. Yssel H. (1995). Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol 7, 1405–16.
25. Dobrzanski M. J. Reome J. B. Dutton R. W. (2001). Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. J Immunol 167, 424–34.
26. Dolgachev V. Petersen B. C. Budelsky A. L. Berlin A. A. Lukacs N. W. (2009). Pulmonary IL-17E (IL-25) production and IL-17RB+ myeloid cell-derived Th2 cytokine production are dependent upon stem cell factor-induced responses during chronic allergic pulmonary disease. J Immunol 183, 5705–15.
27. Druez C. Coulie P. Uyttenhove C. Van Snick J. (1990). Functional and biochemical characterization of mouse P40/IL-9 receptors. J Immunol 145, 2494–99.
28. Eiwegger T. Akdis C. A. (2011). IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol 41, 1535–38.
29. Fang C. Siew L. Q. Corrigan C. J. Ying S. (2010). The role of thymic stromal lymphopoietin in allergic inflammation and chronic obstructive pulmonary disease. Arch Immunol Ther Exp (Warsz) 58, 81–90.
30. Fichtner-Feigl S. Strober W. Kawakami K. Puri R. K. Kitani A. (2006). IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 12, 99–106.
31. F.D., Finkelman, S.P., Hogan, G.G.K., Hershey, M.E., Rothenberg, M., Wills-Karp, Importance of cytokines in murine allergic airway disease and human asthma, J Immunol, (2010), 184, 1663-1674
32. Forbes E. van Panhuys N. Min B. Le Gros G. (2010). Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses. Immunol Cell Biol 88, 240–43.
33. Forbes E. E. Groschwitz K. Abonia J. P. Brandt E. B. Cohen E. Blanchard C. Ahrens R. Seidu L. McKenzie A. Strait R. Finkelman F. D. Foster P. S. Matthaei K. I. Rothenberg M. E. Hogan S. P. (2008). IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 205, 897–913.
34. Fort M. M. Cheung J. Yen D. Li J. Zurawski S. M. Lo S. Menon S. Clifford T. Hunte B. Lesley R. Muchamuel T. Hurst S. D. Zurawski G. Leach M. W. Gorman D. M. Rennick D. M. (2001). IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985–95.
35. Friend S. L. Hosier S. Nelson A. Foxworthe D. Williams D. E. Farr A. (1994). A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol 22, 321–28.
36. Gessner A. Mohrs K. Mohrs M. (2005). Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 174, 1063–72.
37. Gordon S. Martinez F. O. (2010). Alternative activation of macrophages: Mechanism and functions. Immunity 32, 593–604.
38. Goswami R. Kaplan M. H. (2011). A brief history of IL-9. J Immunol 186, 3283–88.
39. Hamid Q. Tulic M. (2009). Immunobiology of asthma. Annu Rev Physiol 71, 489–507.
40. Harada M. Hirota T. Jodo A. I. Doi S. Kameda M. Fujita K. Miyatake A. Enomoto T. Noguchi E. Yoshihara S. Ebisawa M. Saito H. Matsumoto K. Nakamura Y. Ziegler S. F. Tamari M. (2009). Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol 40, 368–74.
41. Harada M. Hirota T. Jodo A. I. Hitomi Y. Sakashita M. Tsunoda T. Miyagawa T. Doi S. Kameda M. Fujita K. Miyatake A. Enomoto T. Noguchi E. Masuko H. Sakamoto T. Hizawa N. Suzuki Y. Yoshihara S. Adachi M. Ebisawa M. Saito H. Matsumoto K. Nakajima T. Mathias R.A. Rafaels N. Barnes K. C. Himes B. E. Duan Q. L. Tantisira K. G. Weiss S. T. Nakamura Y. Ziegler S. F. Tamari M. (2011). Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol 44, 787–93.
42. Harris N. L. Watt V. Ronchese F. Le Gros G. (2002). Differential T cell function and fate in lymph node and nonlymphoid tissues. J Exp Med 195, 317–26.
43. Hayakawa H. Hayakawa M. Kume A. Tominaga S.-I. (2007). Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282, 26369–80.
44. He R. Geha R. S. (2010). Thymic stromal lymphopoietin. Ann N Y Acad Sci 1183, 13–24.
45. Heller N. M. Qi X. Junttila I. S. Shirey K. A. Vogel S. N. Paul W. E. Keegan A. D. (2008). Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci Signal 1, ra17.
46. Hendeles L. Asmus M. Chesrown S. (2004). Evaluation of cytokine modulators for asthma. Paediatr Respir Rev 5, S107–S112.
47. Hoshino T. Winkler-Pickett R. T. Mason A. T. Ortaldo J. R. Young H. A. (1999). IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 162, 51–59.
48. Hsu C.-L. Neilsen C. V. Bryce P. J. (2010). IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLOS One, 5.
49. Hültner L. Kölsch S. Stassen M. Kaspers U. Kremer J.-P. Mailhammer R. Moeller J. Broszeit H. Schmitt E. (2000). In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9. J Immunol 164, 5556–63.
50. Hunninghake G. M. Soto-Quirós M. E. Avila L. Kim H. P. Lasky-Su J. Rafaels N. Ruczinski I. Beaty T. H. Mathias R. A. Barnes K. C. Wilk J. B. O’Connor G. T. James Gauderman W. Vora H. Baurley J. W. Gilliland F. Liang C. Sylvia J. S. Klanderman B. J. Sharma S. S. Himes B. E. Bossley C. J. Israel E. Raby B. A. Bush A. Choi A. M. Weiss S. T. Celedón J. C. (2010). TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy 65, 1566–75.
51. Hvid M. Vestergaard C. Kemp K. Christensen G. B. Deleuran B. Deleuran M. (2011). IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131, 150–57.
52. Iikura M. Suto H. Kajiwara N. Oboki K. Ohno T. Okayama Y. Saito H. Galli S. J. Nakae S. (2007). IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87, 971–78.
53. Ikeda K. Nakajima H. Suzuki K. Kagami S.-I. Hirose K. Suto A. Saito Y. Iwamoto I. (2003). Mast cells produce interleukin-25 upon Fc∊RI-mediated activation. Blood 101, 3594–96.
54. Iwakura Y. Ishigame H. Saijo S. Nakae S. (2011). Functional specialization of interleukin-17 family members. Immunity 34, 149–62.
55. Jung T. Wijdenes J. Neumann C. de Vries J. E. Yssel H. (1996). Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: Modulation by interleukin-4 and interleukin-12. Eur J Immunol 26, 571–77.
56. Kang C.-M. Jang A.-S. Ahn M.-H. Shin J.-A. Kim J.-H. Choi Y.-S. Rhim T.-Y. Park C.-S. (2005). Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol 33, 290–96.
57. Kaplan M. H. Schindler U. Smiley S. T. Grusby M. J. (1996). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313–19.
58. Kay A. B. Barata L. Meng Q. Durham S. R. Ying S. (1997). Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 113, 196–99.
59. Kearley J. Buckland K. F. Mathie S. A. Lloyd C. M. (2009). Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 179, 772–81.
60. Kearley J. Erjefalt J. S. Andersson C. Benjamin E. Jones C. P. Robichaud A. Pegorier S. Brewah Y. Burwell T. J. Bjermer L. Kiener P. A. Kolbeck R. Lloyd C. M. Coyle A. J. Humbles A. A. (2011). IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 183, 865–75.
61. Kleinschek M. A. Owyang A. M. Joyce-Shaikh B. Langrish C. L. Chen Y. Gorman D. M. Blumenschein W. M. McClanahan T. Brombacher F. Hurst S. D. Kastelein R. A. Cua D. J. (2007). IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med 204, 161–70.
62. Kondo Y. Yoshimoto T. Yasuda K. Futatsugi-Yumikura S. Morimoto M. Hayashi N. Hoshino T. Fujimoto J. Nakanishi K. (2008). Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 20, 791–800.
63. Kopf M. Gros G. L. Bachmann M. Lamers M. C. Bluethmann H. Kohler G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245–48.
64. Kurowska-Stolarska M. Stolarski B. Kewin P. Murphy G. Corrigan C. J. Ying S. Pitman N. Mirchandani A. Rana B. van Rooijen N. Shepherd M. McSharry C. McInnes I. B. Xu D. Liew F. Y. (2009). IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 183, 6469–77.
65. Larché M. Robinson D. S. Kay A. B. (2003). The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 111, 450–63.
66. Larson R. P. Zimmerli S. C. Comeau M. R. Itano A. Omori M. Iseki M. Hauser C. Ziegler S. F. (2010). Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses. J Immunol 184, 2974–84.
67. Leckie M. J. Brinke A. T. Khan J. Diamant Z. O’Connor B. J. Walls C. M. Mathur A. K. Cowley H. C. Chung K. F. Djukanovic R. Hansel T. T. Holgate S. T. Sterk P. J. Barnes P. J. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response. Lancet 356, 2144–48.
68. Li H. Sim T. C. Alam R. (1996). IL-13 released by and localized in human basophils. J Immunol 156, 4833–38.
69. Liew F. Y. Pitman N. I. McInnes I. B. (2010). Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat Rev Immunol 10, 103–10.
70. Lisbonne M. Diem S. de Castro Keller A. Lefort J. Araujo L. M. Hachem P. Fourneau J.-M. Sidobre S. Kronenberg M. Taniguchi M. Van Endert P. Dy M. Askenase P. Russo M. Vargaftig B. B. Herbelin A. Leite-de-Moraes M. C. (2003). Cutting edge: Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 171, 1637–41.
71. Liu X. Li M. Wu Y. Zhou Y. Zeng L. Huang T. (2009). Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 386, 181–85.
72. Lloyd C. M. Hessel E. M. (2010). Functions of T cells in asthma: More than just TH2 cells. Nat Rev Immunol 10, 838–48.
73. Longphre M. Li D. Gallup M. Drori E. Ordoñez C. L. Redman T. Wenzel S. Bice D. E. Fahy J. V. Basbaum C. (1999). Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 104, 1375–82.
74. Louahed J. Toda M. Jen J. Hamid Q. Renauld J.-C. Levitt R. C. Nicolaides N. C. (2000). Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 22, 649–56.
75. MacGlashan, D. Jr, White, J. M., Huang, S. K., Ono, S. J., Schroeder, J. T., and Lichtenstein, L. M. (1994). Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 152, 3006–16.
76. Matsuda A. Ebihara N. Yokoi N. Kawasaki S. Tanioka H. Inatomi T. de Waal Malefyt R. Hamuro J. Kinoshita S. Murakami A. (2010). Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 51, 151–55.
77. McNamara P. S. Flanagan B. F. Baldwin L. M. Newland P. Hart C. A. Smyth R. L. (2004). Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363, 1031–37.
78. Mitchell J. Dimov V. Townley R. G. (2010). IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease. Curr Opin Investig Drugs 11, 527–34.
79. Miyata M. Hatsushika K. Ando T. Shimokawa N. Ohnuma Y. Katoh R. Suto H. Ogawa H. Masuyama K. Nakao A. (2008). Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 38, 1487–92.
80. Mosmann T. R. Bond M. W. Coffman R. L. Ohara J. Paul W. E. (1986). T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci U S A 83, 5654–58.
81. Mosmann T. R. Coffman R. L. (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7, 145–73.
82. Mou Z. Xia J. Tan Y. Wang X. Zhang Y. Zhou B. Li H. Han D. (2009). Overexpression of thymic stromal lymphopoietin in allergic rhinitis. Acta Otolaryngol 129, 297–301.
83. Moulin D. Donze O. Talabot-Ayer D. Mezin F. Palmer G. Gabay C. (2007). Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40, 216–25.
84. Moussion C. Ortega N. Girard J.-P. (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel “alarmin”? PLOS One 3, e3331.
85. Munitz A. Brandt E. B. Mingler M. Finkelman F. D. Rothenberg M. E. (2008). Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis. Proc Natl Acad Sci U S A 105, 7240–45.
86. D.R., Neill, A.A.J., McKenzie, TH9: The latest addition to the expanding repertoire of IL-25 targets, Immunol Cell Biol, (2010), 88, 502-504
87. D.R., Neill, S.H., Wong, A., Bellosi, R.J., Flynn, M., Daly, T.T.A., Langford, C., Bucks, C.M., Kane, P.G., Fallon, R., Pannell, H.E., Jolin, A.N.J., McKenzie, Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity, Nature, (2010), 464, 1367-1370
88. Nelms K. Keegan A. D. Zamorano J. Ryan J. J. Paul W. E. (1999). The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 17, 701–38.
89. Nowak E. C. Weaver C. T. Turner H. Begum-Haque S. Becher B. Schreiner B. Coyle A. J. Kasper L. H. Noelle R. J. (2009). IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 206, 1653–60.
90. Oh C. K. Geba G. P. Molfino N. (2010). Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma. Eur Respir Rev 19, 46–54.
91. Oshikawa K. Kuroiwa K. Tago K. Iwahana H. Yanagisawa K. Ohno S. Tominaga S.-I. Sugiyama Y. (2001). Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164, 277–81.
92. Paul W. E. (2010). What determines Th2 differentiation, in vitro and in vivo? Immunol Cell Biol 88, 236–39.
93. Pouliot P. Turmel V. Gélinas É. Laviolette M. Bissonnette É. Y. (2005). Interleukin-4 production by human alveolar macrophages. Clin Exp Allergy 35, 804–10.
94. Préfontaine D. Lajoie-Kadoch S. Foley S. Audusseau S. Olivenstein R. Halayko A. J. Lemière C. Martin J. G. Hamid Q. (2009). Increased expression of IL-33 in severe asthma: Evidence of expression by airway smooth muscle cells. J Immunol 183, 5094–103.
95. Préfontaine D. Nadigel J. Chouiali F. Audusseau S. Semlali A. Chakir J. Martin J. G. Hamid Q. (2010). Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 125, 752–54.
96. Pushparaj P. N. Tay H. K. H’ng S. C. Pitman N. Xu D. McKenzie A. Liew F. Y. Melendez A. J. (2009). The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106, 9773–78.
97. Quentmeier H. Drexler H. G. Fleckenstein D. Zaborski M. Armstrong A. Sims J. E. Lyman S. D. (2001). Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Leukemia 15, 1286–92.
98. Reader J. R. Hyde D. M. Schelegle E. S. Aldrich M. C. Stoddard A. M. McLane M. P. Levitt R. C. Tepper J. S. (2003). Interleukin-9 induces mucus cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol 28, 664–72.
99. Reche P. A. Soumelis V. Gorman D. M. Clifford T. Liu M.-R. Travis M. Zurawski S. M. Johnston J. Liu Y.-J. Spits H. de Waal Malefyt R. Kastelein R. A. Bazan J. F. (2001). Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 167, 336–43.
100. Reynolds J. M. Angkasekwinai P. Dong C. (2010). IL-17 family member cytokines: Regulation and function in innate immunity. Cytokine Growth Factor Rev 21, 413–23.
101. E.A., Rickel, L.A., Siegel, B.-R.P., Yoon, J.B., Rottman, D.G., Kugler, D.A., Swart, P.M., Anders, J.E., Tocker, M.R., Comeau, A.L., Budelsky, Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities, J Immunol, (2008), 181, 4299-4310
102. Rimoldi M. Chieppa M. Larghi P. Vulcano M. Allavena P. Rescigno M. (2005). Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106, 2818–26.
103. Roussel L. Erard M. Cayrol C. Girard J. P. (2008). Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 9, 1006–12.
104. Saenz S. A. Siracusa M. C. Perrigoue J. G. Spencer S. P. Urban J. F. Jr Tocker J. E. Budelsky A. L. Kleinschek M. A. Kastelein R. A. Kambayashi T. Bhandoola A. Artis D. (2010). IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 464, 1362–66.
105. Secrist H. DeKruyff R. H. Umetsu D. T. (1995). Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 181, 1081–89.
106. Seder R. A. Paul W. E. Ben-Sasson S. Z. LeGros G. S. Kagey-Sobotka A. Finkelman F. D. Pierce J. H. Plaut M. (1991). Production of interleukin-4 and other cytokines following stimulation of mast cell lines and in vivo mast cells/basophils. Int Arch Allergy Appl Immunol 94, 137–40.
107. Shimbara A. Christodoulopoulos P. Soussi-Gounni A. Olivenstein R. Nakamura Y. Levitt R. C. Nicolaides N. C. Holroyd K. J. Tsicopoulos A. Lafitte J.-J. Wallaert B. Hamid Q. A. (2000). IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma. J Allergy Clin Immunol 105, 108–15.
108. Shimizu M. Matsuda A. Yanagisawa K. Hirota T. Akahoshi M. Inomata N. Ebe K. Tanaka K. Sugiura H. Nakashima K. Tamari M. Takahashi N. Obara K. Enomoto T. Okayama Y. Gao P.-S. Huang S.-K. Tominaga S.-I. Ikezawa Z. Shirakawa T. (2005). Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 14, 2919–27.
109. Siegle J. Hansbro N. Herbert C. Rosenberg H. Domachowske J. Asquith K. Foster P. Kumar R. (2010). Early-life viral infection and allergen exposure interact to induce an asthmatic phenotype in mice. Respir Res 11, 14.
110. Sonobe Y. Takeuchi H. Kataoka K. Li H. Jin S. Mimuro M. Hashizume Y. Sano Y. Kanda T. Mizuno T. Suzumura A. (2009). Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase C epsilon-dependent manner. J Biol Chem 284, 31834–42.
111. Soumelis V. Reche P.A. Kanzler H. Yuan W. Edward G. Homey B. Gilliet M. Ho S. Antonenko S. Lauerma A. Smith K. Gorman D. Zurawski S. Abrams J. Menon S. McClanahan T. de Waal-Malefyt R. Bazan F. Kastelein R. A. Liu Y.J. (2002). Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3, 673–80.
112. Stassen M. Arnold M. Hültner L. Müller C. Neudörfl C. Reineke T. Schmitt E. (2000). Murine bone marrow-derived mast cells as potent producers of IL-9: Costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol 164, 5549–55.
113. Steenwinckel V. Louahed J. Lemaire M. M. Sommereyns C. Warnier G. McKenzie A. Brombacher F. Van Snick J. Renauld J.-C. (2009). IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa. J Immunol 182, 4737–43.
114. Steenwinckel V. Louahed J. Orabona C. Huaux F. Warnier G. McKenzie A. Lison D. Levitt R. Renauld J.-C. (2007). IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol 178, 3244–51.
115. Taylor B. C. Zaph C. Troy A. E. Du Y. Guild K. J. Comeau M. R. Artis D. (2009). TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med 206, 655–67.
116. Temann U.-A. Geba G. P. Rankin J. A. Flavell R. A. (1998). Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 188, 1307–20.
117. Temann U.-A. Laouar Y. Eynon E.E. Homer R. Flavell R. A. (2007). IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 19, 1–10.
118. Temann U.-A. Ray P. Flavell R. A. (2002). Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 109, 29–39.
119. Terashima A. Watarai H. Inoue S. Sekine E. Nakagawa R. Hase K. Iwamura C. Nakajima H. Nakayama T. Taniguchi M. (2008). A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exper Med 205, 2727–33.
120. Umeshita-Suyama R. Sugimoto R. Akaiwa M. Arima K. Yu B. Wada M. Kuwano M. Nakajima K. Hamasaki N. Izuhara K. (2000). Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1: Redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol 12, 1499–509.
121. Uyttenhove C. Simpson R. J. Van Snick J. (1988). Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A 85, 6934–38.
122. van Panhuys N. Tang S. C. Prout M. Camberis M. Scarlett D. Roberts J. Hu-Li J. Paul W. E. Le Gros G. (2008). In vivo studies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiation. Proc Natl Acad Sci U S A, 105, 12423–28.
123. Veldhoen M. Uyttenhove C. van Snick J. Helmby H. Westendorf A. Buer J. Martin B. Wilhelm C. Stockinger B. (2008). Transforming growth factor-β “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9, 1341–46.
124. Vermeer P. D. Harson R. Einwalter L. A. Moninger T. Zabner J. (2003). Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 28, 286–95.
125. Wang Y.-H. Angkasekwinai P. Lu N. Voo K. S. Arima K. Hanabuchi S. Hippe A. Corrigan C. J. Dong C. Homey B. Yao Z. Ying S. Huston D. P. Liu Y.-J. (2007). IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells. J Exp Med 204, 1837–47.
126. Whittaker L. Niu N. Temann U.-A. Stoddard A. Flavell R. A. Ray A. Homer R. J. Cohn L. (2002). Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol 27, 593–602.
127. Woerly G. Lacy P. Younes A. B. Roger N. Loiseau S. Moqbel R. Capron M. (2002). Human eosinophils express and release IL-13 following CD28-dependent activation. J Leukoc Biol 72, 769–79.
128. C.K., Wong, P.P.Y., Cheung, W.K., Ip, C.C.K., Lam, Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-κ-B, Am J Respir Cell Mol Biol, (2005), 33, 186-194
129. Ying S. O’Connor B. Ratoff J. Meng Q. Fang C. Cousins D. Zhang G. Gu S. Gao Z. Shamji B. Edwards M. J. Lee T. H. Corrigan C. J. (2008). Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 181, 2790–98.
130. Yoo J. Omori M. Gyarmati D. Zhou B. Aye T. Brewer A. Comeau M. R. Campbell D. J. Ziegler S. F. (2005). Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202, 541–49.
131. Zaph C. Du Y. Saenz S. A. Nair M. G. Perrigoue J. G. Taylor B. C. Troy A. E. Kobuley D. E. Kastelein R. A. Cua D. J. Yu Y. Artis D. (2008). Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine. J Exp Med 205, 2191–98.
132. Zheng X. Ma P. de Paiva C. S. Cunningham M. A. Hwang C. S. Pflugfelder S. C. Li D.-Q. (2010). TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci 51, 3076–82.
133. Zhiguang X. Wei C. Steven R. Wei D. Wei Z. Rong M. Zhanguo L. Lianfeng Z. (2010). Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunol Lett 131, 159–65.
134. Zhou B. Comeau M. R. De Smedt T. Liggitt H. D. Dahl M. E. Lewis D. B. Gyarmati D. Aye T. Campbell D. J. Ziegler S. F. (2005). Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 6, 1047–53.
135. Zhu D. D. Zhu X. W. Jiang X. D. Dong Z. (2009). Thymic stromal lymphopoietin expression is increased in nasal epithelial cells of patients with mugwort pollen sensitive-seasonal allergic rhinitis. Chin Med J (Engl) 122, 2303–7.
136. Ziegler S. F. Artis D. (2010). Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11, 289–93.